Repligen Corporation
RGEN
$157.39
-$4.27-2.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.53% | 7.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.53% | 7.80% | |||
| Cost of Revenue | -1.21% | 14.87% | |||
| Gross Profit | 8.09% | 1.78% | |||
| SG&A Expenses | 6.13% | -0.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.96% | 8.16% | |||
| Operating Income | 31.79% | 1.78% | |||
| Income Before Tax | -6.06% | 129.32% | |||
| Income Tax Expenses | -34.28% | 58.50% | |||
| Earnings from Continuing Operations | 0.30% | 154.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.30% | 154.99% | |||
| EBIT | 31.79% | 1.78% | |||
| EBITDA | 10.05% | 5.49% | |||
| EPS Basic | 0.23% | 154.48% | |||
| Normalized Basic EPS | -7.04% | 28.65% | |||
| EPS Diluted | 0.00% | 160.00% | |||
| Normalized Diluted EPS | -7.07% | 29.04% | |||
| Average Basic Shares Outstanding | 0.06% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.04% | -0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||